
    
      To assess the impact of 12 months of vitamin K1 supplementation (plus vitamin D and calcium
      supplementation to avoid deficiency of these problematic nutrients) at a level which leads to
      dramatically (i.e greater than 70%) reduced levels of undercarboxylated osteocalcin - a
      functional marker of vitamin K status, on vitamin K status, the rate of bone formation and
      bone resorption, using biochemical markers of bone turnover, and bone mineral density in
      adult patients with longstanding Crohn's disease.
    
  